Pigeon Corporation (TYO:7956)
2,155.50
+36.50 (1.72%)
Aug 21, 2026, 3:30 PM JST
Pigeon Revenue
Pigeon had revenue of 29.49B JPY in the quarter ending June 30, 2026, with 3.44% growth. This brings the company's revenue in the last twelve months to 114.41B, up 7.34% year-over-year. In the year 2025, Pigeon had annual revenue of 109.17B with 4.80% growth.
Revenue (ttm)
114.41B
Revenue Growth
+7.34%
P/S Ratio
2.25
Revenue / Employee
37.61M
Employees
3,042
Market Cap
257.48B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.17B | 5.00B | 4.80% |
| Dec 31, 2024 | 104.17B | 9.71B | 10.28% |
| Dec 31, 2023 | 94.46B | -460.00M | -0.48% |
| Dec 31, 2022 | 94.92B | 1.84B | 1.98% |
| Dec 31, 2021 | 93.08B | -6.30B | -6.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Lion Corporation | 439.47B |
| Rohto Pharmaceutical | 353.39B |
| KOSE Holdings | 334.58B |
| Cawachi | 285.45B |
| Genky DrugStores | 220.64B |
| Earth | 185.57B |
| Pola Orbis Holdings | 171.38B |
| Kobayashi Pharmaceutical | 167.47B |
Pigeon News
- 14 days ago - Pigeon Quarterly report: Q2 2026 - Filings
- 14 days ago - Pigeon Slides: Q2 2026 - Filings
- 3 months ago - Pigeon Quarterly report: Q1 2026 - Filings
- 3 months ago - Pigeon Slides: Q1 2026 - Filings
- 6 months ago - Pigeon Quarterly report: Q4 2025 - Filings
- 6 months ago - Pigeon Slides: Q4 2025 - Filings
- 10 months ago - Pigeon Quarterly report: Q3 2025 - Filings
- 10 months ago - Pigeon Slides: Q3 2025 - Filings